Globus Medical Q4 revenue $826.4M (+25.7% YoY); EPS $1.03 GAAP / $1.28 non-GAAP

GLOBUS MEDICAL INC

2025-FY EPS reported $3.92 revenue$2,938,931,000

Q4 worldwide net sales $826.4M, up 25.7% YoY; base business ex-Nevro up 10.6%.
GAAP diluted EPS $1.03 (vs $0.19); non-GAAP diluted EPS $1.28 (vs $0.84), up 52.1%.
Full year 2025 revenue $2,938.9M (+16.7%); GAAP EPS $3.92; non-GAAP EPS $3.98.
2026 guidance: revenue $3.18-3.22B; non-GAAP EPS raised to $4.40-4.50 from $4.30-4.40.
US Spine revenue grew 10% in Q4; Enabling Technologies grew 19% over prior-year quarter.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.